Table: Modalis Therapeutics -Q1 group results

Modalis Therapeutics

08/05/2025 07:33

May 8 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2025        Mar 31, 2024     Dec 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Operating     loss 632 mln        loss 490 mln                  
  Recurring     loss 651 mln        loss 457 mln                  
  Net           loss 652 mln        loss 457 mln                  
  EPS           loss 9.02 yen      loss 13.57 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T